Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-10-057595
Filing Date
2010-03-16
Accepted
2010-03-16 06:18:36
Documents
12
Period of Report
2009-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1172066
2 FORM OF AMENDED WARRANT dex47.htm EX-4.7 53339
3 AMENDED PURCHASE OPTION AGREEMENT dex1047.htm EX-10.47 326347
4 WARRANT PURCHASE AGREEMENT dex1048.htm EX-10.48 267595
5 AMENDED REGISTRATION RIGHTS AGREEMENT dex1049.htm EX-10.49 98684
6 STANDSTILL AND CORPORATE GOVERNANCE AGREEMENT dex1050.htm EX-10.50 22860
7 LIST OF SUBSIDIARIES dex211.htm EX-21.1 756
8 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 2604
9 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 dex311.htm EX-31.1 10596
10 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 dex312.htm EX-31.2 10542
11 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 dex321.htm EX-32.1 4188
12 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 906 dex322.htm EX-32.2 4188
  Complete submission text file 0001193125-10-057595.txt   1975196
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34207 | Film No.: 10683655
SIC: 2834 Pharmaceutical Preparations